Skip to content

Karman Line: Strategy-game supported treatment for slowed information processing speed (IPS)

Karman Line: Strategy-game supported treatment for slowed information processing speed (IPS) - KARMAN_TPM

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51933
Enrollment
60
Registered
2021-01-06
Start date
2021-11-16
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

niet-aangeboren hersenletsel acquired brain injury brain damage

Interventions

The investigational treatment is based on the standard TPM training, part of the cognitive rehabilitation intervention at Klimmendaal rehabilitation center that is used for ABI patients with slowed

Sponsors

Revalidatiecentrum Groot Klimmendaal
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age: 18-70 Non-progressive acquired brain injury Minimal time post-onset of 3 months Outpatient rehabilitation Living independently at home Slowed information processing speed (assessment by MSQ, score >= 13)

Exclusion criteria

Exclusion criteria: Inability to speak/understand the Dutch language Severe psychiatric problems (history) Neurogenerative disorders Substance abuse Severe cognitive comorbidity (eg dementia) Unable to look at a computer screen for more than 15 minutes Unable to operate a keyboard and/or a computer mouse No access to a smartphone, and laptop or tablet Aphasia Neglect

Design outcomes

Primary

MeasureTime frame
The main study parameter is strategy-use measured by an experimental task that investigates the application of cognitive strategies in an online meeting (int. al. the percentage change of the number of correct strategies). Participants perform the task before and after treatment (two counterbalanced parallel versions).

Secondary

MeasureTime frame
Our secondary objectives are to investigate the subjective experience of treatment outcomes and strategy-use in daily life. This will be measured by GAS (Goal Attainment Scaling) and by a questionnaire with questions about strategy-use in daily life (Vragenlijst Omgaan met Tijdsdruk). Moreover, questionnaires and neuropsychological tests will be administered.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)